Enovis Corporation to Participate in Investor Conferences in August and September.
ByAinvest
Friday, Aug 8, 2025 9:03 am ET1min read
ENOV--
Enovis Corporation is dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The company's extensive range of products, services, and integrated technologies fuels active lifestyles in orthopedics and beyond. Enovis' shares of common stock are listed on the New York Stock Exchange under the symbol ENOV.
The Canaccord Genuity 45th Annual Growth Conference is scheduled for August 13th at 8:30 a.m. ET, the Wells Fargo Healthcare Conference is set for September 3rd at 2:15 p.m. ET, and the Baird 2025 Global Healthcare Conference will take place on September 10th at 3:10 p.m. ET. Live audio webcasts and replays of these events will be accessible through the Investors section of the company's website under Events and Presentations.
References:
1. [1] https://ir.enovis.com/stock-information/historic-stock-lookup
2. [2] https://www.stocktitan.net/news/ENOV/enovis-to-participate-in-upcoming-investor-1y2zg1jfdxp4.html
3. [3] https://www.globenewswire.com/news-release/2025/08/08/3130159/0/en/Enovis-to-Participate-in-Upcoming-Investor-Conferences.html
4. [4] https://www.marketscreener.com/news/enovis-announces-second-quarter-2025-results-ce7c5edfd881f023
WFC--
Enovis Corporation, a medical technology growth company, announced that its management team will participate in three investor conferences: Canaccord Genuity 45th Annual Growth Conference, Wells Fargo Healthcare Conference, and Baird 2025 Global Healthcare Conference. The events will be webcast live on the company's website. Enovis Corporation is focused on developing clinically differentiated solutions to improve patient outcomes and transform workflows.
Enovis Corporation (NYSE: ENOV), a leading medical technology growth company, has announced its participation in three major investor conferences. The events, which will be webcast live on the company's website, include the Canaccord Genuity 45th Annual Growth Conference, the Wells Fargo Healthcare Conference, and the Baird 2025 Global Healthcare Conference. These conferences will provide investors with an opportunity to engage with Enovis' management team and gain insights into the company's strategic initiatives and financial performance.Enovis Corporation is dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The company's extensive range of products, services, and integrated technologies fuels active lifestyles in orthopedics and beyond. Enovis' shares of common stock are listed on the New York Stock Exchange under the symbol ENOV.
The Canaccord Genuity 45th Annual Growth Conference is scheduled for August 13th at 8:30 a.m. ET, the Wells Fargo Healthcare Conference is set for September 3rd at 2:15 p.m. ET, and the Baird 2025 Global Healthcare Conference will take place on September 10th at 3:10 p.m. ET. Live audio webcasts and replays of these events will be accessible through the Investors section of the company's website under Events and Presentations.
References:
1. [1] https://ir.enovis.com/stock-information/historic-stock-lookup
2. [2] https://www.stocktitan.net/news/ENOV/enovis-to-participate-in-upcoming-investor-1y2zg1jfdxp4.html
3. [3] https://www.globenewswire.com/news-release/2025/08/08/3130159/0/en/Enovis-to-Participate-in-Upcoming-Investor-Conferences.html
4. [4] https://www.marketscreener.com/news/enovis-announces-second-quarter-2025-results-ce7c5edfd881f023
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet